Stephen Wargacki - Mar 9, 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP, Research & Development
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Mar 9, 2024
Transactions value $
-$63,225
Form type
4
Date filed
3/12/2024, 01:46 PM
Previous filing
Aug 9, 2023
Next filing
May 13, 2024
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Tax liability -$55K -11.3K -4.16% $4.88 260K Mar 9, 2024 Direct F1
transaction AQST Common Stock Tax liability -$8.23K -1.69K -0.65% $4.88 258K Mar 10, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.